Concepts (108)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Butyrates | 3 | 2022 | 167 | 1.330 |
Why?
|
| Benzoxazoles | 3 | 2022 | 92 | 1.320 |
Why?
|
| PPAR alpha | 3 | 2022 | 177 | 1.280 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2020 | 693 | 0.580 |
Why?
|
| Phosphodiesterase 3 Inhibitors | 2 | 2012 | 11 | 0.510 |
Why?
|
| Angiopoietins | 1 | 2015 | 86 | 0.480 |
Why?
|
| Urea | 2 | 2012 | 448 | 0.420 |
Why?
|
| Lameness, Animal | 1 | 2012 | 7 | 0.410 |
Why?
|
| Adipose Tissue, White | 1 | 2015 | 371 | 0.400 |
Why?
|
| Hindlimb | 2 | 2012 | 516 | 0.360 |
Why?
|
| Quinolines | 2 | 2012 | 772 | 0.340 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2015 | 1124 | 0.320 |
Why?
|
| Macrophages | 2 | 2020 | 5799 | 0.230 |
Why?
|
| Peripheral Arterial Disease | 2 | 2012 | 1304 | 0.220 |
Why?
|
| Oxidation-Reduction | 2 | 2020 | 2227 | 0.220 |
Why?
|
| Cyclopentanes | 1 | 2019 | 87 | 0.170 |
Why?
|
| Lipid Metabolism | 2 | 2020 | 1904 | 0.160 |
Why?
|
| Disease Models, Animal | 4 | 2020 | 18349 | 0.160 |
Why?
|
| Carbohydrate Metabolism | 1 | 2020 | 262 | 0.160 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2019 | 151 | 0.160 |
Why?
|
| Furans | 1 | 2019 | 199 | 0.150 |
Why?
|
| T-Lymphocytes | 1 | 2015 | 10266 | 0.140 |
Why?
|
| Triglycerides | 2 | 2022 | 2464 | 0.130 |
Why?
|
| Fluorouracil | 1 | 2020 | 1652 | 0.120 |
Why?
|
| Drug Design | 1 | 2019 | 1046 | 0.120 |
Why?
|
| Insulin Resistance | 2 | 2019 | 3986 | 0.110 |
Why?
|
| Hepatocytes | 1 | 2020 | 1247 | 0.100 |
Why?
|
| Obesity | 1 | 2015 | 13090 | 0.100 |
Why?
|
| Dendritic Cells | 2 | 2017 | 2747 | 0.100 |
Why?
|
| Models, Molecular | 2 | 2019 | 5403 | 0.100 |
Why?
|
| Antigens, Differentiation | 1 | 2015 | 921 | 0.100 |
Why?
|
| Liver | 2 | 2020 | 7577 | 0.100 |
Why?
|
| Glucose Tolerance Test | 1 | 2015 | 1183 | 0.100 |
Why?
|
| Antioxidants | 1 | 2020 | 1673 | 0.100 |
Why?
|
| Fatty Acids | 1 | 2019 | 1812 | 0.100 |
Why?
|
| Gastric Bypass | 1 | 2019 | 824 | 0.090 |
Why?
|
| Adenoviridae | 1 | 2015 | 1092 | 0.090 |
Why?
|
| Lipopolysaccharides | 1 | 2017 | 2219 | 0.080 |
Why?
|
| Animals | 10 | 2022 | 169246 | 0.080 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2022 | 2333 | 0.080 |
Why?
|
| Nitric Oxide | 1 | 2017 | 2146 | 0.080 |
Why?
|
| Vascular System Injuries | 1 | 2012 | 248 | 0.080 |
Why?
|
| Hypersensitivity | 1 | 2017 | 1172 | 0.080 |
Why?
|
| Glucose | 1 | 2019 | 4352 | 0.070 |
Why?
|
| Vasodilator Agents | 1 | 2012 | 990 | 0.070 |
Why?
|
| Mice | 6 | 2022 | 82029 | 0.070 |
Why?
|
| Endothelial Cells | 1 | 2020 | 3589 | 0.070 |
Why?
|
| Cell Movement | 2 | 2017 | 5210 | 0.070 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2015 | 4352 | 0.060 |
Why?
|
| Liver Neoplasms | 1 | 2022 | 4362 | 0.060 |
Why?
|
| Genetic Vectors | 1 | 2015 | 3402 | 0.060 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2012 | 8128 | 0.060 |
Why?
|
| Receptors, Immunologic | 1 | 2009 | 1418 | 0.050 |
Why?
|
| Gene Expression Regulation | 1 | 2019 | 11928 | 0.050 |
Why?
|
| Interferon-gamma | 1 | 2009 | 3160 | 0.050 |
Why?
|
| Colorectal Neoplasms | 1 | 2020 | 6974 | 0.040 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2012 | 2763 | 0.040 |
Why?
|
| Rats | 2 | 2012 | 23760 | 0.040 |
Why?
|
| HCT116 Cells | 1 | 2020 | 404 | 0.040 |
Why?
|
| Gluconeogenesis | 1 | 2019 | 185 | 0.040 |
Why?
|
| Insulin-Like Growth Factor Binding Proteins | 1 | 2019 | 208 | 0.040 |
Why?
|
| Molecular Conformation | 1 | 2019 | 540 | 0.040 |
Why?
|
| Administration, Oral | 2 | 2019 | 4030 | 0.040 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2019 | 414 | 0.030 |
Why?
|
| Glucosides | 1 | 2022 | 533 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2015 | 22379 | 0.030 |
Why?
|
| Muscle, Skeletal | 1 | 2012 | 4978 | 0.030 |
Why?
|
| Signal Transduction | 2 | 2020 | 23645 | 0.030 |
Why?
|
| Benzhydryl Compounds | 1 | 2022 | 944 | 0.030 |
Why?
|
| Crystallography, X-Ray | 1 | 2019 | 1951 | 0.030 |
Why?
|
| Humans | 7 | 2020 | 768166 | 0.030 |
Why?
|
| Immunization | 1 | 2017 | 1219 | 0.030 |
Why?
|
| Endocytosis | 1 | 2017 | 956 | 0.030 |
Why?
|
| Lauric Acids | 1 | 2012 | 9 | 0.030 |
Why?
|
| Antigen Presentation | 1 | 2017 | 1251 | 0.020 |
Why?
|
| Antigens | 1 | 2017 | 1442 | 0.020 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2020 | 3556 | 0.020 |
Why?
|
| Male | 5 | 2020 | 364719 | 0.020 |
Why?
|
| Intestines | 1 | 2019 | 1909 | 0.020 |
Why?
|
| Cyclohexanones | 1 | 2009 | 30 | 0.020 |
Why?
|
| Platelet Aggregation | 1 | 2012 | 769 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2017 | 6231 | 0.020 |
Why?
|
| Regional Blood Flow | 1 | 2012 | 1500 | 0.020 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 2009 | 705 | 0.020 |
Why?
|
| Blood Flow Velocity | 1 | 2012 | 1375 | 0.020 |
Why?
|
| Receptors, IgE | 1 | 2009 | 375 | 0.020 |
Why?
|
| Vasodilation | 1 | 2012 | 967 | 0.020 |
Why?
|
| COS Cells | 1 | 2009 | 1135 | 0.020 |
Why?
|
| Necrosis | 1 | 2012 | 1616 | 0.020 |
Why?
|
| Proteomics | 1 | 2019 | 3912 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2019 | 6430 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2020 | 11244 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 2009 | 3055 | 0.010 |
Why?
|
| Benzamides | 1 | 2009 | 1379 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2020 | 8647 | 0.010 |
Why?
|
| Ligands | 1 | 2009 | 3284 | 0.010 |
Why?
|
| Environmental Exposure | 1 | 2017 | 4543 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 4580 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2009 | 6124 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2012 | 10760 | 0.010 |
Why?
|
| Aging | 1 | 2017 | 8744 | 0.010 |
Why?
|
| Cytokines | 1 | 2009 | 7453 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2020 | 65371 | 0.010 |
Why?
|
| Time Factors | 1 | 2012 | 40218 | 0.010 |
Why?
|
| Aged | 1 | 2020 | 171504 | 0.000 |
Why?
|
| Middle Aged | 1 | 2020 | 223492 | 0.000 |
Why?
|
| Adult | 1 | 2020 | 223646 | 0.000 |
Why?
|
| Female | 1 | 2020 | 397192 | 0.000 |
Why?
|
Concepts
(108)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(7)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_